{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:39:17Z","timestamp":1778733557884,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T00:00:00Z","timestamp":1194393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s11926-007-0078-y","type":"journal-article","created":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T06:26:18Z","timestamp":1194330378000},"page":"482-487","source":"Crossref","is-referenced-by-count":75,"title":["Chronic fatigue syndrome: Inflammation, immune function, and neuroendocrine interactions"],"prefix":"10.1007","volume":"9","author":[{"given":"Nancy G.","family":"Klimas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne O\u2019Brien","family":"Koneru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,7]]},"reference":[{"key":"78_CR1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","volume":"121","author":"K. Fukada","year":"1994","unstructured":"Fukada K, Straus S, Hickie I: The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994, 121:953\u2013959.","journal-title":"Ann Intern Med"},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0140-6736(91)91440-6","volume":"338","author":"A. Landay","year":"1991","unstructured":"Landay A, Jessop C, Lennette E, Levy J: Chronic fatigue syndrome: Clinical condition associated with immune activation. Lancet 1991, 338:707\u2013712.","journal-title":"Lancet"},{"key":"78_CR3","first-page":"26","volume-title":"Handbook of Chronic Fatigue Syndrome","author":"A. Plioplys","year":"2003","unstructured":"Plioplys A: Differential diagnosis in medical assessment. In Handbook of Chronic Fatigue Syndrome. Edited by Jason L, Fennel P, Taylor R. Hoboken: John Wiley and Sons; 2003:26\u201341."},{"key":"78_CR4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2249.2005.02935.x","volume":"142","author":"K.J. Maher","year":"2005","unstructured":"Maher KJ, Klimas NG, Fletcher MA: Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol 2005, 142:505\u2013511.","journal-title":"Clin Exp Immunol"},{"key":"78_CR5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","volume":"333","author":"I. Hickie","year":"2006","unstructured":"Hickie I, Davenport T, Wakefield D, et al.: Post-infective and chronic fatigue syndromes precipitated by viral pathogens: Prospective cohort study. BMJ 2006, 333:575.","journal-title":"BMJ"},{"key":"78_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/08916930701197273","volume":"40","author":"S. Appel","year":"2007","unstructured":"Appel S, Chapman J, Shoenfeld Y: Infections and vaccination in chronic fatigue syndrome: Myth or reality. Autoimmunity 2007, 40:48\u201353.","journal-title":"Autoimmunity"},{"key":"78_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2005.11.002","volume":"90","author":"M. Maes","year":"2006","unstructured":"Maes M, Mihaylova I, De Ruyter M: Lower serum zinc in chronic fatigue syndrome (CFS): Relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord 2006, 90:141\u2013147.","journal-title":"J Affect Disord"},{"key":"78_CR8","first-page":"745","volume":"26","author":"M. Maes","year":"2005","unstructured":"Maes M, Mihaylova I, Leunis JC: In chronic fatigue syndrome, the decreased levels of omega-3 poly unsaturated fatty acids are related to lower serum zinc and defects in T cell activation. Neuro Endocrinol Lett 2005, 26:745\u2013751.","journal-title":"Neuro Endocrinol Lett"},{"key":"78_CR9","first-page":"615","volume":"27","author":"M. Maes","year":"2006","unstructured":"Maes M, Mihaylova I, Leunis JC: Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett 2006, 27:615\u2013621.","journal-title":"Neuro Endocrinol Lett"},{"key":"78_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/jcp.2006.042424","volume":"60","author":"B.K. Puri","year":"2007","unstructured":"Puri BK: Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome). J Clin Pathol 2007, 60:122\u2013124.","journal-title":"J Clin Pathol"},{"key":"78_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jcp.2005.035956","volume":"60","author":"H. Grans","year":"2007","unstructured":"Grans H, Nilsson M, Dahlman-Wright K, Evengard B: Reduced levels of oestrogen receptor B (beta) mRNA in Swedish patients with chronic fatigue syndrome. J. Clin Pathol 2007, 60:195\u2013198.","journal-title":"J. Clin Pathol"},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0165-0327(95)00026-J","volume":"34","author":"A.J. Cleare","year":"1995","unstructured":"Cleare AJ, Bearn J, Allain T, et al.: Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 1995, 34:283\u2013289.","journal-title":"J Affect Disord"},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jcem-73-6-1224","volume":"73","author":"M.A. Demitrack","year":"1991","unstructured":"Demitrack MA, Dale JK, Straus SE, et al.: Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991, 73:1224\u20131234.","journal-title":"J Clin Endocrinol Metab"},{"key":"78_CR14","doi-asserted-by":"crossref","unstructured":"Ter Wolbeek M, van Doornen LJ, Kavelaars A, et al.: Longitudinal analysis of pro-and anti-inflammatory cytokine production in severely fatigued adolescents. Brain Behav Immun 2007, Epub ahead of print.","DOI":"10.1016\/j.bbi.2007.04.007"},{"key":"78_CR15","doi-asserted-by":"crossref","first-page":"10552","DOI":"10.1073\/pnas.89.21.10552","volume":"89","author":"Z.N. Berneman","year":"1992","unstructured":"Berneman ZN, Ablashi DV, Li G, et al.: Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci 1992, 89:10552\u201310556.","journal-title":"Proc Natl Acad Sci"},{"key":"78_CR16","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0140-6736(01)06961-6","volume":"358","author":"P.D. White","year":"2001","unstructured":"White PD, Thomas JM, Kangro HO, et al.: Predictions and associations of fatigue syndrome and mood disorders that occur after infectious mononucleosis. Lancet 2001, 358:1946\u20131954.","journal-title":"Lancet"},{"issue":"Suppl1","key":"78_CR17","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S1386-6532(06)70011-7","volume":"37","author":"S. Chapenko","year":"2006","unstructured":"Chapenko S, Krumina A, Kozireva S, et al.: Activation of human herpesvirus 6 and 7 in patients with chronic fatigue syndrome. J Clin Virol 2006, 37(Suppl 1):S47\u2013S51.","journal-title":"J Clin Virol"},{"key":"78_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hci149","volume":"99","author":"I. Petersen","year":"2006","unstructured":"Petersen I, Thomas JM, Hamilton WT, White PD: Risk and predictors of fatigue after infectious mononucleosis in a large primary care cohort. QJM 2006; 99:49\u201355.","journal-title":"QJM"},{"issue":"Suppl1","key":"78_CR19","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1093\/clinids\/18.Supplement_1.S126","volume":"18","author":"J.W. Gow","year":"1994","unstructured":"Gow JW, Behan WM, Simpson K, et al.: Studies on enterovirus in patients with chronic fatigue syndrome. Clin Infect Dis 1994, 18(Suppl 1):S126\u2013S129.","journal-title":"Clin Infect Dis"},{"key":"78_CR20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jad.2006.08.021","volume":"99","author":"M. Maes","year":"2007","unstructured":"Maes M, Mihaylova I, Leunis JC: Increased serum IgA and IgM against LPS of enterobacteria higher in chronic fatigue syndrome (CFS): Indication for the involvement of gramnegative bacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J Affect Disord 2007, 99:237\u2013240.","journal-title":"J Affect Disord"},{"key":"78_CR21","doi-asserted-by":"crossref","unstructured":"Chia JK, Chia AY: Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol 2007, Epub ahead of print.","DOI":"10.1136\/jcp.2007.050054"},{"key":"78_CR22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.psyneuen.2006.12.005","volume":"32","author":"W.K. Jerjes","year":"2007","unstructured":"Jerjes WK, Taylor NF, Wood PJ, Cleare AJ: Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology 2007 32:192\u2013198.","journal-title":"Psychoneuroendocrinology"},{"key":"78_CR23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1601-183X.2006.00244.x","volume":"6","author":"M.S. Rajeevan","year":"2007","unstructured":"Rajeevan MS, Smith AK, Dimulescu I, et al.: Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav 2007, 6:167\u2013176.","journal-title":"Genes Brain Behav"},{"key":"78_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2334-6-15","volume":"6","author":"S.D. Vernon","year":"2006","unstructured":"Vernon SD, Whistler T, Cameron B, et al.: Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus. BMC Infect Dis 2006, 6:15.","journal-title":"BMC Infect Dis"},{"key":"78_CR25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/JCM.28.6.1403-1410.1990","volume":"28","author":"N.G. Klimas","year":"1990","unstructured":"Klimas NG, Salvato FR, Morgan R, Fletcher MA: Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990, 28:1403\u20131410.","journal-title":"J Clin Microbiol"},{"key":"78_CR26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0140-6736(91)91440-6","volume":"338","author":"A.L. Landay","year":"1991","unstructured":"Landay AL, Jessop C, Lennette ET, Levy JA: Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991, 338:707\u2013712.","journal-title":"Lancet"},{"key":"78_CR27","first-page":"124","volume-title":"Handbook of Chronic Fatigue Syndrome","author":"K. Maher","year":"2003","unstructured":"Maher K, Klimas N, Fletcher MA: Immunology. In Handbook of Chronic Fatigue Syndrome. Edited by Jason L, Fennel P, Taylor R. Hoboken: John Wiley and Sons; 2003:124\u2013151."},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.4049\/jimmunol.139.10.3306","volume":"139","author":"M. Caligiuri","year":"1987","unstructured":"Caligiuri M, Murray C, Buchwald D, et al.: Phenotypic and functional deficiency in natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987, 139:3306\u20133313.","journal-title":"J Immunol"},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jpsychores.2006.03.001","volume":"60","author":"S.D. Siegel","year":"2006","unstructured":"Siegel SD, Antoni MH, Fletcher MA, et al.: Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: Preliminary evidence for a subgroup? J Psychosom Res 2006, 60:559\u2013566.","journal-title":"J Psychosom Res"},{"key":"78_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jcp.2006.042374","volume":"60","author":"J.R. Kerr","year":"2007","unstructured":"Kerr JR, Hodgetts A, Langford PR, et al.: Current research priorities in chronic fatigue syndrome\/myalgic encephalitis: Disease mechanisms, a diagnostic test and specific treatments. J Clin Pathol 2007, 60:113\u2013116.","journal-title":"J Clin Pathol"},{"issue":"Suppl1","key":"78_CR31","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S1386-6532(06)70009-9","volume":"37","author":"A.M. Kogelnik","year":"2006","unstructured":"Kogelnik AM, Loomis K, Hoegh-Petersen M, et al.: Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. J Clin Virol 2006, 37Suppl 1:S33\u2013S38.","journal-title":"J Clin Virol"},{"key":"78_CR32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1358\/dot.2002.38.8.820095","volume":"38","author":"A.M. Lerner","year":"2002","unstructured":"Lerner AM, Beqaj SH, Deeter RG, et al.: A six-month trial of valganciclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function. Drugs Today (Barc). 2002, 38:549\u2013561.","journal-title":"Drugs Today (Barc)"},{"key":"78_CR33","first-page":"399","volume":"56","author":"K. Lundell","year":"2006","unstructured":"Lundell K, Qazi S, Eddy L, Uckun FM: Clinical activity of folinic acid in patients with chronic fatigue syndrome. Arzneimittelforschung 2006, 56:399\u2013404.","journal-title":"Arzneimittelforschung"},{"key":"78_CR34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1479-5876-4-34","volume":"4","author":"R.C. Vermeulen","year":"2006","unstructured":"Vermeulen RC, Scholte HR: Azithromycin in chronic fatigue syndrome (CFS), an analysis of clinical data. J Transl Med 2006, 4:34.","journal-title":"J Transl Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0078-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-007-0078-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0078-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T16:37:35Z","timestamp":1684082255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-007-0078-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,7]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s11926-007-0078-y","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,7]]}}}